Skip to main content
. 2024 Mar 4;16(3):e55477. doi: 10.7759/cureus.55477

Table 5. Treatment outcome of patients with autoimmune hepatitis.

Data given as n (%) and median (IQR) as indicated

Treatment outcome Male (n=25) Female (n=60) p-value Chi-square value
Biochemical and clinical response rate at six months, n (%) 16 (64%) 38 (63.3%) 0.57 20.6
Relapse, n (%) 12/16 (75%) 16/38 (42%) 0.02 12.8
Time to relapse after stopping or de-escalating the drugs (months), median (IQR) 9.5 (4-13.5) 8.6 (6-11.75) 0.14 0.78
Five-year mortality, n (%) 4 (16%) ) 8 (13.3%)   0.78 0.03